Literature DB >> 10692996

The molecular basis of isoniazid resistance in Mycobacterium tuberculosis.

B Heym1, B Saint-Joanis, S T Cole.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10692996     DOI: 10.1054/tuld.1998.0208

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


× No keyword cloud information.
  10 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil.

Authors:  Rosilene Fressatti Cardoso; Robert C Cooksey; Glenn P Morlock; Patricia Barco; Leticia Cecon; Francisco Forestiero; Clarice Q F Leite; Daisy N Sato; Maria de Lourdes Shikama; Elsa M Mamizuka; Rosario D C Hirata; Mario H Hirata
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.

Authors:  N Galí; J Domínguez; S Blanco; C Prat; F Alcaide; P Coll; V Ausina
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 4.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

Review 5.  Therapeutic drug monitoring in the treatment of tuberculosis.

Authors:  Charles A Peloquin
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 6.  Genotyping of Mycobacterium tuberculosis using whole genome sequencing.

Authors:  Jana Amlerova; Ibrahim Bitar; Jaroslav Hrabak
Journal:  Folia Microbiol (Praha)       Date:  2018-03-17       Impact factor: 2.099

7.  Anti-mycobacterium tuberculosis activity of polyherbal medicines used for the treatment of tuberculosis in Eastern Cape, South Africa.

Authors:  Elizabeth B Famewo; Anna M Clarke; Ian Wiid; Andile Ngwane; Paul van Helden; Anthony J Afolayan
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

8.  First experience with using simple polymerase chain reaction-based methods as an alternative to phenotypic drug susceptibility testing for Myobacterium tuberculosis in Iraq.

Authors:  Suhad Hadi Mohammed; Mohanad Mohsin Ahmed; Abdul Razak H Ahmed
Journal:  Int J Appl Basic Med Res       Date:  2013-07

9.  Molecular Analysis of katG Encoding Catalase-Peroxidase from Clinical Isolate of Isoniazid-Resistant Mycobacterium tuberculosis.

Authors:  P Purkan; I Ihsanawati; D Natalia; Y M Syah; D S Retnoningrum; I Siswanto
Journal:  J Med Life       Date:  2018 Apr-Jun

Review 10.  Challenges in the development of drugs for the treatment of tuberculosis.

Authors:  Adeeb Shehzad; Gauhar Rehman; Mazhar Ul-Islam; Waleed Ahmad Khattak; Young Sup Lee
Journal:  Braz J Infect Dis       Date:  2013-01-01       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.